APA (7th ed.) Citation

MD, G., S, D., S, I., E, G., KG, C., S, L., . . . SK, P. (2024). Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine, 30(4), 1211. https://doi.org/10.1038/s41591-024-02814-0

Chicago Style (17th ed.) Citation

MD, Galsky, et al. "Author Correction: Gemcitabine and Cisplatin Plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial." Nature Medicine 30, no. 4 (2024): 1211. https://doi.org/10.1038/s41591-024-02814-0.

MLA (9th ed.) Citation

MD, Galsky, et al. "Author Correction: Gemcitabine and Cisplatin Plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial." Nature Medicine, vol. 30, no. 4, 2024, p. 1211, https://doi.org/10.1038/s41591-024-02814-0.